Literature DB >> 12175452

Flavor improvement does not increase abuse liability of nicotine chewing gum.

Elisabeth J Houtsmuller1, Reginald V Fant, Thomas E Eissenberg, Jack E Henningfield, Maxine L Stitzer.   

Abstract

Because the taste of nicotine gum has impeded compliance with dosing recommendations, nicotine gum with improved taste (mint, orange) was developed and marketed. Prior to marketing, the Food and Drug Administration (FDA) required a rigorous abuse liability assessment to examine whether enhanced palatability of nicotine gum would increase its abuse liability. Subjective, physiological, and psychomotor effects of mint flavor and original nicotine gum were tested in adult smokers (22-55 years old); a group of younger subjects (18-21 years old) was also included to allow for assessment of abuse liability in young adults specifically. Amphetamine and confectionery gum served as positive controls for abuse liability and palatability. Subjects rated palatability of mint gum higher than original nicotine gum, but substantially lower than confectionery gum. Palatability decreased with increasing dose of nicotine. Neither original nor mint gum increased ratings of traditional abuse liability predictors [Good Effect, Like Effect, Morphine-Benzedrine Group (MBG) scales of Addiction Research Center Inventory (ARCI)], while amphetamine increased ratings of all these measures. Both flavors of nicotine gum decreased craving during 2 h of abstinence. These effects were more pronounced in the adult group and mint gum was more effective than original gum. Younger subjects reported fewer withdrawal symptoms and lower ratings for drug effects and flavor. Improved flavor of nicotine gum does not increase abuse liability, but may be associated with enhanced craving reduction.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12175452     DOI: 10.1016/s0091-3057(02)00723-2

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  15 in total

1.  Nicotine reinforcement in never-smokers.

Authors:  Angela N Duke; Matthew W Johnson; Chad J Reissig; Roland R Griffiths
Journal:  Psychopharmacology (Berl)       Date:  2015-09-08       Impact factor: 4.530

2.  Validation of the human odor span task: effects of nicotine.

Authors:  David A MacQueen; David J Drobes
Journal:  Psychopharmacology (Berl)       Date:  2017-07-14       Impact factor: 4.530

Review 3.  Knowledge synthesis of smoking cessation among employed and unemployed young adults.

Authors:  Pearl Bader; Heather E Travis; Harvey A Skinner
Journal:  Am J Public Health       Date:  2007-06-28       Impact factor: 9.308

4.  Nicotine flux: a potentially important tool for regulating electronic cigarettes.

Authors:  Thomas Eissenberg; Alan Shihadeh
Journal:  Nicotine Tob Res       Date:  2014-10-19       Impact factor: 4.244

5.  Conference on abuse liability and appeal of tobacco products: conclusions and recommendations.

Authors:  Jack E Henningfield; Dorothy K Hatsukami; Mitch Zeller; Ellen Peters
Journal:  Drug Alcohol Depend       Date:  2011-03-03       Impact factor: 4.492

6.  Nicotine delivery and pharmacologic response from Verve, an oral nicotine delivery product.

Authors:  Bartosz Koszowski; Lauren C Viray; Stephen B Stanfill; Joseph G Lisko; Zach R Rosenberry; Jennifer L Potts; Wallace B Pickworth
Journal:  Pharmacol Biochem Behav       Date:  2015-06-19       Impact factor: 3.533

Review 7.  Abuse liability assessment of tobacco products including potential reduced exposure products.

Authors:  Lawrence P Carter; Maxine L Stitzer; Jack E Henningfield; Rich J O'Connor; K Michael Cummings; Dorothy K Hatsukami
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-12       Impact factor: 4.254

Review 8.  Principles of laboratory assessment of drug abuse liability and implications for clinical development.

Authors:  Lawrence P Carter; Roland R Griffiths
Journal:  Drug Alcohol Depend       Date:  2009-05-14       Impact factor: 4.492

9.  Positive allosteric modulation of α4β2 nicotinic acetylcholine receptors as a new approach to smoking reduction: evidence from a rat model of nicotine self-administration.

Authors:  Xiu Liu
Journal:  Psychopharmacology (Berl)       Date:  2013-05-28       Impact factor: 4.530

10.  Caffeine's influence on nicotine's effects in nonsmokers.

Authors:  Melissa D Blank; Bethea A Kleykamp; Janine M Jennings; Thomas Eissenberg
Journal:  Am J Health Behav       Date:  2007 Sep-Oct
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.